|
|
|
Insider
Information: |
Cook David N |
Relationship: |
SVP, Chief Scientific ... |
City: |
Concord |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
232,740 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$168,553 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
232,740 |
|
|
Total
Value |
$168,553 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cerus Corp |
CERS |
Vice President, R & D |
2007-01-05 |
43,836 |
2004-03-19 |
0 |
Premium* |
|
Seres Therapeutics, Inc. |
MCRB |
See Remarks |
2019-01-26 |
147,435 |
|
0 |
Premium* |
|
Forma Therapeutics Holdings, Inc., |
FMTX |
SVP, Chief Scientific ... |
2022-02-28 |
41,469 |
2021-02-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CERS |
Cerus Corp |
Vice President, R & D |
|
2004-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11,500 |
33,833 |
|
- |
|
CERS |
Cerus Corp |
officerTitle |
|
2006-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,033 |
37,866 |
|
- |
|
CERS |
Cerus Corp |
Vice President, R & D |
|
2006-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
50 |
37,916 |
|
- |
|
CERS |
Cerus Corp |
Vice President, R & D |
|
2007-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,970 |
43,836 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
See Remarks |
|
2015-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
45,454 |
229,673 |
0 |
- |
|
FMTX |
Forma Therapeutics Holdin... |
SVP, Chief Scientific Officer |
|
2021-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
FMTX |
Forma Therapeutics Holdin... |
SVP, Chief Scientific Officer |
|
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
41,469 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
Chief Scientific Officer & EVP |
|
2016-04-01 |
4 |
AS |
$25.74 |
$1,371,586 |
D/D |
(53,000) |
176,673 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
Chief Scientific Officer & EVP |
|
2016-04-04 |
4 |
AS |
$28.00 |
$224,000 |
D/D |
(8,000) |
168,673 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
Chief Scientific Officer & EVP |
|
2016-04-07 |
4 |
AS |
$31.00 |
$248,000 |
D/D |
(8,000) |
160,673 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
Chief Scientific Officer & EVP |
|
2016-06-01 |
4 |
AS |
$29.43 |
$470,880 |
D/D |
(16,000) |
144,673 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
Chief Scientific Officer & EVP |
|
2016-06-02 |
4 |
AS |
$31.00 |
$248,000 |
D/D |
(8,000) |
136,673 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
CSO and EVP of R&DOfficer |
|
2015-06-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
184,219 |
|
- |
|
MCRB |
Seres Therapeutics, Inc. |
See Remarks |
|
2018-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
141,673 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
See Remarks |
|
2019-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
147,435 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
See Remarks |
|
2018-01-26 |
4 |
S |
$11.02 |
$19,153 |
D/D |
(1,738) |
139,935 |
0 |
- |
|
FMTX |
Forma Therapeutics Holdin... |
SVP, Chief Scientific Officer |
|
2022-02-23 |
4 |
S |
$9.78 |
$34,524 |
D/D |
(3,531) |
16,469 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|